Methyl-hydroxylation and subsequent oxidation to produce carboxylic acid is the major metabolic pathway of tolbutamide in chimeric TK-NOG mice transplanted with human hepatocytes

Abstract Tolbutamide is an oral anti-hyperglycaemic agent used to treat non-insulin–dependent diabetes mellitus with species-dependent metabolic profiles. In this study, we investigated tolbutamide metabolism in chimeric TK-NOG mice transplanted with human hepatocytes (humanised-liver mice). Substantial 4-hydroxytolbutamide and 4-carboxytolbutamide production was observed in hepatocytes from humanised-liver mice (Hu-Liver cells) and humans, whereas 4-carboxytolbutamide production was not detected in mouse hepatocytes. In Hu-Liver cells, 4-hydroxytolbutamide formation was inhibited by sulfaphenazole (CYP2C9 inhibitor), whereas 4-carboxytolbutamide formation was inhibited by raloxifene/ethinyloestradiol (aldehyde oxidase inhibitor) and disulfiram (aldehyde dehydrogenase inhibitor). After a single oral dose of tolbutamide (10 mg/kg), the plasma levels of 4-carboxytolbutamide and p-tolylsulfonylurea were higher in humanised-liver mice than in TK-NOG mice. Urinary excretion was the predominant route (>99% of unchanged drug and metabolites detected in excreta) of elimination in both groups. 4-Carboxytolbutamide was the most abundant metabolite in humanised-liver mouse urine, as similarly reported for humans, whereas 4-hydroxytolbutamide was predominantly excreted in TK-NOG mouse urine. These results suggest that humanised-liver mice might represent a suitable animal model for studying the successive oxidative metabolism of tolbutamide by multiple drug-metabolising enzymes. Future work is warranted to study the general nature of primary alcohol metabolism using humanised-liver mice.

[1]  H. Yamazaki,et al.  Metabolism of desloratadine by chimeric TK-NOG mice transplanted with human hepatocytes , 2020, Xenobiotica; the fate of foreign compounds in biological systems.

[2]  H. Yamazaki,et al.  Human Aldehyde Oxidase 1–Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes , 2020, Drug Metabolism and Disposition.

[3]  M. Romão,et al.  Evolution, expression, and substrate specificities of aldehyde oxidase enzymes in eukaryotes , 2020, The Journal of Biological Chemistry.

[4]  H. Yamazaki,et al.  Prediction of circulating human metabolites of pemafibrate, a novel antidyslipidemic drug, using chimeric mice with humanized liver , 2019, Xenobiotica; the fate of foreign compounds in biological systems.

[5]  C. Wolf,et al.  An Extensively Humanized Mouse Model to Predict Pathways of Drug Disposition and Drug/Drug Interactions, and to Facilitate Design of Clinical Trials , 2019, Drug Metabolism and Disposition.

[6]  Amaj Ahmed Laskar,et al.  Aldehyde toxicity and metabolism: the role of aldehyde dehydrogenases in detoxification, drug resistance and carcinogenesis , 2019, Drug metabolism reviews.

[7]  H. Yamazaki,et al.  Expression and inducibility of cytochrome P450s in human hepatocytes isolated from chimeric mice with humanised livers , 2018, Xenobiotica; the fate of foreign compounds in biological systems.

[8]  K. Bissig,et al.  P450-Humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity , 2018, Drug Metabolism and Disposition.

[9]  H. Yamazaki,et al.  Chimeric mice with humanized liver as a model for testing organophosphate and carbamate pesticide exposure , 2018, Pest management science.

[10]  Andrew S. Felts,et al.  Species-Specific Involvement of Aldehyde Oxidase and Xanthine Oxidase in the Metabolism of the Pyrimidine-Containing mGlu5-Negative Allosteric Modulator VU0424238 (Auglurant) , 2017, Drug Metabolism and Disposition.

[11]  R. Tukey,et al.  Species differences in drug glucuronidation: Humanized UDP-glucuronosyltransferase 1 mice and their application for predicting drug glucuronidation and drug-induced toxicity in humans. , 2017, Drug metabolism and pharmacokinetics.

[12]  M. Romão,et al.  Structure and function of mammalian aldehyde oxidases , 2016, Archives of Toxicology.

[13]  H. Suemizu,et al.  Formation of the Accumulative Human Metabolite and Human-Specific Glutathione Conjugate of Diclofenac in TK-NOG Chimeric Mice with Humanized Livers , 2015, Drug Metabolism and Disposition.

[14]  C. Wolf,et al.  Deletion of 30 Murine Cytochrome P450 Genes Results In Viable Mice With Compromised Drug Metabolism , 2014, Drug Metabolism and Disposition.

[15]  R. Nirogi,et al.  Identification of a suitable and selective inhibitor towards aldehyde oxidase catalyzed reactions , 2014, Xenobiotica; the fate of foreign compounds in biological systems.

[16]  M. Siddiqui,et al.  Expression and inducibility of cytochrome P450s (CYP1A1, 2B6, 2E1, 3A4) in human cord blood CD34(+) stem cell-derived differentiating neuronal cells. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  Vindhya Koppaka,et al.  Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical Application , 2012, Pharmacological Reviews.

[18]  M. Suematsu,et al.  The reconstituted 'humanized liver' in TK-NOG mice is mature and functional. , 2011, Biochemical and biophysical research communications.

[19]  T. Haseba,et al.  A New View of Alcohol Metabolism and Alcoholism—Role of the High-Km Class III Alcohol Dehydrogenase (ADH3) , 2010, International journal of environmental research and public health.

[20]  M. Fratelli,et al.  The mammalian aldehyde oxidase gene family , 2009, Human Genomics.

[21]  R. de Kanter,et al.  Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction , 2006, Expert opinion on drug metabolism & toxicology.

[22]  H. Jörnvall,et al.  Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. , 1999, Biochemical pharmacology.

[23]  M. Rashidi,et al.  In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[24]  F. Guengerich,et al.  Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition. , 1987, The Journal of pharmacology and experimental therapeutics.

[25]  C. Tyson,et al.  Comparative metabolism of tolbutamide by isolated hepatocytes from rat, rabbit, dog, and squirrel monkey. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[26]  E. Algar,et al.  Purification and molecular properties of mouse alcohol dehydrogenase isozymes. , 1983, European journal of biochemistry.

[27]  B. Vallee,et al.  Isolation of pi-alcohol dehydrogenase of human liver: is it a determinant of alcoholism? , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Pietruszko.  Human liver alcohol dehydrogenase--inhibition of methanol activity by pyrazole, 4-methylpyrazole, 4-hydroxymethylpyrazole and 4-carboxypyrazole. , 1975, Biochemical pharmacology.

[29]  V. Massey,et al.  On the mechanism of inactivation of xanthine oxidase by allopurinol and other pyrazolo[3,4-d]pyrimidines. , 1970, The Journal of biological chemistry.

[30]  R. Bressler,et al.  The metabolism of tolbutamide in rat liver. , 1969, The Journal of pharmacology and experimental therapeutics.

[31]  R. Thomas,et al.  The metabolic fate of tolbutamide in man and in the rat. , 1966, Journal of medicinal chemistry.

[32]  C. Brown,et al.  Cytochromes P450: a structure-based summary of biotransformations using representative substrates. , 2008, Drug metabolism reviews.

[33]  T. Baillie,et al.  Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism. , 2008, Chemical research in toxicology.

[34]  S. Kitamura,et al.  Drug-metabolizing ability of molybdenum hydroxylases. , 2006, Drug metabolism and pharmacokinetics.

[35]  Július,et al.  THE METABOLISM OF , 2003 .

[36]  J. Miners,et al.  Use of tolbutamide as a substrate probe for human hepatic cytochrome P450 2C9. , 1996, Methods in enzymology.

[37]  M. Tsutsumi,et al.  Hepatic aldehyde dehydrogenase isoenzymes: differences with respect to species. , 1988, Alcohol.

[38]  HighWire Press,et al.  Drug metabolism and disposition : the biological fate of chemicals. , 1973 .